submit your manuscript | www.dovepress.com Objective: Bamboo is distributed worldwide, and its different parts are used as foods or as a traditional herb. Recently, antitumoral effects of bamboo extracts on several tumors have been increasingly reported; however, antitumoral activity of bamboo extracts on osteosarcoma remains unclear. In the present study, we investigated effects of an aqueous Phyllostachys edulis leaf extract (PEE) on osteosarcoma cells and the underlying mechanism of inhibition.
Introduction
Osteosarcoma is a primary bone tumor which is believed to be derived from malignant mesenchymal stem cells. 1 The tumors mostly occur in the metaphyses of long bones, particularly the distal femur, the proximal tibia, and the proximal humerus. 2 Although the application of neoadjuvant chemotherapy coupled with local control has ameliorated the outcomes of osteosarcoma patients in the past decades, the 5-year survival rate remains approximately 65%, and the rates after recurrence or metastasis are dramatically lowered to 30%. 3, 4 In addition, osteosarcoma patients with metastasis to other tissues such as lung usually decease in 6-12 months. 5 Therefore, the mining of the therapeutic compounds and/or investigation of molecular mechanisms to suppress tumor progression is urgent and critical to develop effective osteosarcoma treatment. Use of herbal medicine has gained increased interest as an alternative for treating neoplastic disorders.
There are approximately 1,050 different species of bamboo in the world, from the tiny Sasa to the subtropical giants. Bamboo is widely distributed, and several edible parts constitute a range of important nutrients. Leaves of bamboo have been utilized in traditional Chinese medicine for treating fever and inflammation for centuries. Bamboo leaf extracts have been demonstrated to possess different biological and pharmacological activities including antioxidant activity and anti-inflammatory activity. 6, 7 Recently, antitumor effects of bamboo extracts on different cancers such as tongue squamous carcinoma and colon cancer have been increasingly investigated. [8] [9] [10] [11] However, the functional components of antitumor activity and the underlying mechanisms remain unclear and need further investigation. Moreover, the therapeutic effects of herbal remedies need to be justified in different age groups of patients. [12] [13] [14] Adenosine monophosphate (AMP)-activated protein kinase (AMPK) is an important sensor for cellular energy level in all eukaryotic cells. AMPK is activated under conditions of low intracellular ATP (adenosine triphosphate) attributing to nutrient deprivation and hypoxia. 15 Previous studies have shown that AMPK governs important cellular physiology including cell growth, cell proliferation, and autophagy. 16, 17 Activation of AMPK has been reported to be involved in suppressed growth of different carcinoma cells such as HepG2 (liver cancer) and SW620 (colorectal cancer). 18, 19 Recent studies have found that genetic manipulation of the AMPK upstream activator LKB1 is crucial for hepatoma development, 20 and activated AMPK inhibits hepatoma growth by destabilizing p53 in a SIRT1-dependent manner. 21 These findings suggest that AMPK may be considered as a potential target for treating carcinomas.
The present study was aimed to investigate antitumoral effects of an aqueous Phyllostachys edulis leaf extract (PEE) on human osteosarcoma cells and the underlying mechanism, with emphasis on AMPK signaling.
Materials and methods

Preparation of PEE
The young leaves of bamboo P. edulis were collected and washed with distilled water. Five grams of the leaves were homogenized with 20 mL of distilled water. The homogenate was heated at 95°C for 30 minutes to inactivated proteins, and then filtered through gauze. After centrifugation at 15,000× g for 10 minutes, the supernatant was passed through an ultrafiltration membrane (1 kDa cutoff), lyophilized (PEE), and then stored at -70°C for subsequent experiments.
Cell culture and experimental treatments
Human osteosarcoma cell lines 143B and MG-63 and human non-tumor lung fibroblast MRC-5 cells were purchased from American Type Culture Collection (ATCC; Rockville, MD, USA) and maintained in Dulbecco's Modified Eagle Medium (DMEM; Gibco BRL, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (Gibco BRL) and 100 µg/mL penicillin/streptomycin (Gibco BRL, Basel, Switzerland) at 37°C in a humidified atmosphere containing 5% CO 2 . Cells were seeded at a density of 1×10 5 cells/mL and cultured for 24 hours to reach 80% confluence. For experiments, 80% confluent cells were treated with serial concentrations of PEE (w/v) in serum-free DMEM for 24 or 48 hours. After the treatments, the cells were washed with phosphate-buffered saline (PBS) and collected for subsequent assays.
Cell viability assay
Cell viability was determined using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay as previously described. 22 After 24 or 48 hours incubation with PEE or 5-aminoimidazole-4-carboxamide 1-β-D-ribofuranoside (AICAR; Sigma-Aldrich, St Louis, MO, USA) at serial concentrations, culture medium was aspirated, and the cells were washed with PBS followed by incubation with MTT (0.5 mg/mL) at 37°C for 4 hours. After incubation, the supernatant was removed, and the cells were given with isopropanol to dissolve formazan. Concentration of formazan was determined by measuring the absorbance at 570 nm using SpectraMAX 360 pc microplate reader (Molecular Devices, Sunnyvale, CA, USA).
Cellular apoptosis assay
The apoptotic cells were detected using terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) system according to the manufacturer's instructions (Promega, Madison, WI, USA). For nuclei staining, 4′,6-diamidino-2-phenylindole (DAPI) was used. Signal detection was performed using fluorescence microscopy (LSM 710; Carl-Zeiss, Oberkochen, Germany). The apoptotic index was presented as average percentages of positive nuclei including apoptotic bodies per total number of nuclei from five random observation fields at 200× magnitudes. Three 
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Bamboo extract induced apoptosis of osteosarcoma 143B independent experiments were performed for statistical analysis.
Flow cytometric analysis for cell cycle distribution
Cells were synchronized at G0 phase by serum starvation for 16 hours and subsequently incubated in fresh serumcontaining medium to allow cell-cycle progression. At designated time points, cells released from G0 arrest were analyzed using a flow cytometer (FACSCalibur™; BD Biosciences, San Jose, CA, USA). At the end of treatment, cells were harvested, fixed with 1 mL of ice-cold 70% ethanol, and centrifuged at 400× g for 5 minutes at room temperature. Cell pellets were stained with l mL of 20 µg/mL propidium iodide for 15 minutes, protected from light. The resulting samples were analyzed using FACS Calibur system (BD Biosciences) incorporating with CellQuest software (version 5.1).
Immunoblotting
After treatments, cells were washed with PBS twice and then lysed with lysis buffer (50 mM Tris-HCl, pH 7.5, 1% Nonidet P-40; Sigma-Aldrich) supplemented with protease inhibitor cocktail (Roche, Mannheim, Germany). The cell lysates were centrifuged at 20,000× g for 15 minutes, and then the resulting supernatants were collected for protein quantitation using BCA method (Pierce Biotechnology, Rockford, IL, USA) and the subsequent analyses. Of each sample, 20 µg protein was subjected to a 12.5% SDS (sodium dodecyl sulfate)-polyacrylamide gel followed by a transfer onto a nitrocellulose membrane (Millipore, Bedford, MA, USA). The blotted membrane was blocked with 5% w/v skimmed milk, incubated with primary antibodies (1/1,000 dilution) for 2 hours, flowed by an incubation with peroxidase-conjugated secondary antibodies (1/2,000 dilution). Primary antibodies against caspase-3, caspase-8, caspase-9, Bax, Bcl-2, phosphorylated AMPK at threonine 172, AMPK, and poly(ADP-ribose) polymerase (PARP) were purchased from Cell Signaling Technologies (Beverly, MA, USA). Signal development was performed using ECL (electrochemiluminescence) reagent (Millipore).
Statistical analysis
The data were expressed as mean ± standard deviation of the three independent experiments. Differences between treated groups and control groups were statistically analyzed using Student's t-test or Dunnett's t-test. The differences were considered significant for P-values 0.05.
Results
PEE treatment inhibits cell viability of human osteosarcoma cells
Cytotoxicity of PEE was first investigated by using cell viability assay. Osteosarcoma 143B and MG-63 cells were treated with serial concentrations of PEE (50, 100, 200, and 400 µg/mL) for 24 and 48 hours, and subsequently measured for the cell viability. As shown in Figure 1 , the viability of 143B and MG-63 cells exposed to PEE for both 24 and 48 hours declined in a dose-dependent fashion. In the 24-hour treatment groups, the cell viability was significantly decreased to 55.4%±2.1% (143B) and 56.1%±3.2% (MG-63) of control at concentration of 400 µg/mL PEE, respectively (P0.05 as compared with control). For the 48-hour treatment, the cell viability was further lowered to 42.7%±2.2% and 35.2%±2.8% of control at a concentration of 400 µg/mL PEE, respectively (P0.05 as compared with control). In parallel, cytotoxic effects of PEE on non-tumor lung fibroblast MRC-5 were also explored. Comparing with 143B and MG-63 cells, viability of MRC-5 cell was moderately affected by PEE treatment, and the cell viability was decreased to 83.5%±8.2% (24 hours) and 79.7%±2.8% 
1580
Chou et al (48 hours) of control at concentration of 400 µg/mL PEE, respectively (P0.05 as compared with 143B).
Effects of an AMPK activator AICAR on viability of the osteosarcoma cells were also performed. As shown in Figure 1B , the cell viability was significantly decreased to 41.5%±3.1% (143B) and 38.4%±1.6% (MG-63) of control at concentration of 500 µM AICAR for 48 hours, respectively (P0.05 as compared with control). Interestingly, the changes of viability between 143B and MRC-5 cells in response to AICAR (1,000 µM for 24 and 48 hours and 500 µM for 48 hours) were insignificant (P0.05). Taken together, these findings showed that PEE treatment (200 and 400 µg/mL), similar to AICAR treatment, significantly suppressed the viability of 143B and MG-63 cells.
PEE induces apoptosis of 143B cells
To elucidate the cell death caused by PEE, cell cycle distribution of PEE-treated 143B cells was examined. As shown in Figure 2A , ratios of sub-G1 phase were increased in a dose-dependent manner in the cells with exposure to PEE treatments for 24 hours. The percentage of sub-G1 phase was increased to 32.5%±3.1% (400 µg/mL PEE, P0.05 as compared with control). For AICAR treatment (500 µM), the percentage of sub-G1 phase was increased to 24.3%±2.3% (P0.05 as compared with control). To further evaluate the apoptosis induced by PEE, TUNEL assay was subsequently performed. As shown in Figure 2B , apoptotic index was significantly increased to 33.5%±2.1% in response to PEE (400 µg/mL, P0.05 as compared with control), and the increase of apoptotic cells was dose-dependent. In addition, similar increased apoptotic index (31.1%±1.8%) was also observed in the presence of AICAR. Collectively, these results showed that PEE treatment remarkably induced apoptosis of 143B cells.
PEE activates apoptotic pathway in 143B cells
To further explore apoptosis of 143B cells induced by PEE, the activation of intrinsic and extrinsic caspase cascades was determined. As shown in Figure 3A , the level of procaspase-3, an effecter caspase contributing to DNA fragmentation, was reduced in response to PEE treatments in a dose-dependent fashion. In addition to the reduced procaspase-3, active cleaved caspase-3 was increased in 143B cells with exposure to PEE. We next investigated whether caspase-8 and caspase-9, two upstream activators of caspase-3 in extrinsic and intrinsic pathway, were activated by PEE treatment, and the results revealed that PEE treatments decreased the level of inactive procaspase-8 and procaspase-9 but increased the level of active cleaved caspase-8 (43 kDa) and caspase-9 (35 kDa) in 143B cells. 
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Chou et al and p53 was determined. 23 As shown in Figure 3B , PEE decreased Bcl2 levels but induced increases in Bax and p53 levels. Together, these findings indicate that PEE triggers activation of caspase cascades, which may attribute to suppression of anti-apoptotic Bcl2 and enhancement of pro-apoptotic Bax and p53.
PEE treatment activates AMPK signaling in human osteosarcoma 143B cells
A previous study demonstrated that bamboo leaf extract could induce AMPK signaling and the consequent biological activity. 24 Accordingly, effects of PEE on AMPK signaling were examined. After 24 hours treatment, PEE enhanced AMPK phosphorylation at threonine 172 (Figure 4) . AMPK activation was associated with a decrease in mammalian target of rapamycin (mTOR) and 70 kDa ribosomal protein S6 kinase (P70S6K) phosphorylation (Figure 4 ). Using a well-known AMPK activator, AICAR, similar AMPK phosphorylation at threonine 172 and decreased mTOR and P70S6K was observed in 143B cells (Figure 4) . The findings indicate that AMPK was activated in the presence of PEE in 143B cells.
PEE induced apoptosis and lowered cell viability of 143B cells via AMPK activation
To examine whether AMPK phosphorylation was responsible for PEE-induced cell death, cells were treated with PEE (400 µg/mL) for 24 hours, and apoptotic proteins were analyzed by immunoblotting. The selective AMPK inhibitor compound C diminished PEE-induced caspase-3 and PARP cleavage ( Figure 5A ) and cell growth inhibition (P0.01) ( Figure 5B ). These results suggest that PEE-induced apoptosis and viability suppression are mediated by activating AMPK.
Discussion
In the past few years, several lines of evidence indicate that Phyllostachys spp. extracts or derived products such as bamboo salt possess cancer-preventive or anticancer effects. [8] [9] [10] However, the mechanism that bamboo extracts induces apoptosis or autophagy of tumor cells remains sketchy. In the present study, we first demonstrated that a bamboo leaf extract PEE induced apoptosis and growth inhibition of human osteosarcoma 143B cells via both intrinsic and extrinsic pathways attributing to AMPK activation.
AMPK signaling is an important target with potent antitumor activity; thus, identifying new AMPK activators is pivotal for developing anticancer agents. 18, 25 Recently, several studies have demonstrated that AMPK activators including AICAR and metformin inhibit different types of tumors via AMPK-dependent pathway. [26] [27] [28] The present study revealed that PEE significantly induced AMPK activation and inhibited the downstream P70S6K and mTOR, which may contribute to decreased Bcl2 level and increased Bax level. In addition, our results show that PEE reduced more cell viability of 143B cells as compared with AICAR alone. Taken together, these findings indicate that AMPK activation plays a pivotal role in PEE-induced apoptosis of osteosarcoma 143B cells, but PEE may also suppress viability of 143B cells via AMPK-independent pathways.
Abnormal cells such as neoplastic cells are eliminated and removed by apoptosis, a programmed cell death. 29 The apoptotic cell death pathway is mediated by Bcl2 protein family, a group of anti-apoptotic proteins that regulate the passage of cytochrome c, which binds to apaf-1 to form active apoptosome and then activates the following caspase cascades. 30, 31 Activated caspase-3 exerts as the key executioner of apoptosis to induce the cleavage and inactivation of key cellular protein such as PARP. 32, 33 Our findings revealed that PEE treatment increased Bax level and reduced Bcl2 level, as well as elevated the cleaved caspase-3, caspase-8, and caspase-9 levels, suggesting that PEE could alter Bcl2 proteins and activate apoptotic pathway in osteosarcoma 143B cells. In addition, PEE increased p53 level, which may contribute to G1-phase cell cycle arrest as shown in Figure 2C . Taken together, these findings indicate that PEE possesses potent antitumoral activity on osteosarcoma cells, attributing to induction of apoptosis and cell cycle arrest.
In conclusion, we presented the evidence that PEE treatment significantly suppresses viability of osteosarcoma 143B cells through activation of AMPK and a synergistic effort of apoptotic signaling induction and suppressed antiapoptotic signaling. By regulating both arms of apoptotic and anti-apoptotic signaling, PEE constitutes a pharmacological property that makes it a promising anticancer agent against human osteosarcoma.
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